CoChat

Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment

Open access
Ross-Gillespie, Adin, Weigert, Michael, Brown, Sam P., Kümmerli, Rolf · 2014 · Evolution, Medicine, and Public Health

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVES: Conventional antibiotics select strongly for resistance and are consequently losing efficacy worldwide. Extracellular quenching of shared virulence factors could represent a more promising strategy because (i) it reduces the available routes to resistance (as extracellular action precludes any mutations blocking a drug's entry into cells or hastening its exit) and (ii) it weakens selection for resistance, as fitness benefits to emergent mutants are diluted across all cells in a cooperative collective. Here, we tested this hypothesis empirically. METHODOLOGY: We used gallium to quench the iron-scavenging siderophores secreted and shared among pathogenic Pseudomonas aeruginosa bacteria, and quantitatively monitored its effects on growth in vitro. We assayed virulence in acute infections of caterpillar hosts (Galleria mellonella), and tracked resistance emergence over time using experimental evolution. RESULTS: Gallium strongly inhibited bacterial growth in vitro, primarily via its siderophore quenching activity. Moreover, bacterial siderophore production peaked at intermediate gallium concentrations, indicating additional metabolic costs in this range. In vivo, gallium attenuated virulence and growth-even more so than in infections with siderophore-deficient strains. Crucially, while resistance soon evolved against conventional antibiotic treatments, gallium treatments retained their efficacy over time. CONCLUSIONS: Extracellular quenching of bacterial public goods could offer an effective and evolutionarily robust control strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emph/eou003

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Gallium affects P. aeruginosa’s in vitro growth and siderophore production. (A) Gallium suppresses growth particularly when pyoverdine is present, as shown here by comparing conditions with and without its production. Symbols and bars indicate means and 95% CIs of integrals of spline curves fitted through 24 h growth trajectories (OD at 600 nm) of 12 replicate cultures. (B) Pyoverdine, assayed using complementary approaches, is in each case upregulated at intermediate gallium concentrations. Symbols and error bars represent means and SEs of five replicates. Measures of pyoverdine from supernatant (filled circles) or pvdA expression from cell fractions (open circles) are in each case scaled by cell density (OD at 600 nm).
Figure 1. Gallium affects P. aeruginosa’s in vitro growth and siderophore production. (A) Gallium suppresses growth particularly when pyoverdine is present, as shown here by comparing conditions with and without its production. Symbols and bars indicate means and 95% CIs of integrals of spline curves fitted through 24 h growth trajectories (OD at 600 nm) of 12 replicate cultures. (B) Pyoverdine, assayed using complementary approaches, is in each case upregulated at intermediate gallium concentrations. Symbols and error bars represent means and SEs of five replicates. Measures of pyoverdine from supernatant (filled circles) or pvdA expression from cell fractions (open circles) are in each case scaled by cell density (OD at 600 nm).CC BY · PubMed Central
Figure 2. Gallium attenuates P. aeruginosa virulence and growth in G. mellonella larvae. (A–C) Virulence across treatments, as Kaplan–Meier (stepped lines) and Weibull (smoothed lines) survival curves; proportion surviving (with 95% binomial CIs); and time-to-death (means and 95% CIs). We estimate that inocula with ‘LOW’ (2.5–50 μM), ‘MED’ (500 μM) or ‘HIGH’ (2500 μM) concentrations of Ga(NO3)3 gave in-host concentrations of ∼0.05 to ∼50 μM (see ‘Methodology’ section). (D) Bacterial density in vivo (GFP signal in host homogenate; means and 95% CIs from ∼24 larvae) corrected against saline-injected controls and scaled relative to PAO1 at 13 h. (E) Mean and 95% CIs of bacterial growth integrals derived from bootstrap replicate time series (24 replicate splines) from (D)
Figure 2. Gallium attenuates P. aeruginosa virulence and growth in G. mellonella larvae. (A–C) Virulence across treatments, as Kaplan–Meier (stepped lines) and Weibull (smoothed lines) survival curves; proportion surviving (with 95% binomial CIs); and time-to-death (means and 95% CIs). We estimate that inocula with ‘LOW’ (2.5–50 μM), ‘MED’ (500 μM) or ‘HIGH’ (2500 μM) concentrations of Ga(NO3)3 gave in-host concentrations of ∼0.05 to ∼50 μM (see ‘Methodology’ section). (D) Bacterial density in vivo (GFP signal in host homogenate; means and 95% CIs from ∼24 larvae) corrected against saline-injected controls and scaled relative to PAO1 at 13 h. (E) Mean and 95% CIs of bacterial growth integrals derived from bootstrap replicate time series (24 replicate splines) from (D)CC BY · PubMed Central
Figure 3. Evolutionary potential for resistance against gallium treatment. (A–D) Over the course of experimental evolution, daily growth integrals for cultures treated with various antibiotics rose significantly, while the growth of gallium treated cultures did not. (E) Slope coefficients for linear fits through data in (A–D), expressed as % of growth of control at Day 1. In all cases, symbols and error bars show means and 95% CIs of six replicate cultures
Figure 3. Evolutionary potential for resistance against gallium treatment. (A–D) Over the course of experimental evolution, daily growth integrals for cultures treated with various antibiotics rose significantly, while the growth of gallium treated cultures did not. (E) Slope coefficients for linear fits through data in (A–D), expressed as % of growth of control at Day 1. In all cases, symbols and error bars show means and 95% CIs of six replicate culturesCC BY · PubMed Central
Figure 4. Resistance-related phenotypic changes following experimental evolution under gallium treatment. Pyoverdine (A) and pyocyanin (B) production under standardized test conditions (dark bars = LB medium, light bars = CAA medium) of ancestral PAO1, knock-out strains (i.e. negative controls), control lines (evolved without gallium) and gallium-selected lines. Pyoverdine measures are scaled to that of PAO1 in CAA, whereas pyocyanin is scaled to that of PAO1 in LB. Asterisks indicate cases where Ga-selected lines were significantly different from their ancestor and unexposed control lines. Error bars give 95% CIs of 3–6 replicates
Figure 4. Resistance-related phenotypic changes following experimental evolution under gallium treatment. Pyoverdine (A) and pyocyanin (B) production under standardized test conditions (dark bars = LB medium, light bars = CAA medium) of ancestral PAO1, knock-out strains (i.e. negative controls), control lines (evolved without gallium) and gallium-selected lines. Pyoverdine measures are scaled to that of PAO1 in CAA, whereas pyocyanin is scaled to that of PAO1 in LB. Asterisks indicate cases where Ga-selected lines were significantly different from their ancestor and unexposed control lines. Error bars give 95% CIs of 3–6 replicatesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

Items 101–108 of 108

Metadata

Authors
Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R.
Affiliations
University of Zurich (CH)
Venue
Evolution, Medicine, and Public Health
Published
2014-01-01
Volume
2014
Issue
1
Pages
18-29
ISSN
2050-6201 (ISSN-L)
OpenAlex
W2157642827
Cited by
104
References
63
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 6
FWCI
6.70
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Evolution Medicine and Public Health (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DORA Eawag (Swiss Federal Institute of Aquatic Science and Technology (Eawag)) (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
European Commission
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
gallium, Pseudomonas aeruginosa, antibiotic resistance, virulence attenuation, Galleria mellonella, experimental evolution, public goods, iron acquisition, antibiotic therapy, bacterial virulence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.